Patients, n |
64 |
Age, median (range), y |
71 (41–90) |
Sex (male: female) |
47:17 |
Primary disease, n |
|
Pancreatic tumor |
15 |
Bile duct cancer |
10 |
Chronic pancreatitis |
13 |
Bile duct stone |
11 |
Hepaticojejunostomy stricture |
7 |
Other |
8 |
Body mass index, median, (range), kg/m2
|
21.8 (13.0–34.2) |
e-GFR, median (range), mL/min |
71 (6.57–174) |
Mean performance status (±SD) |
0.68 ± 0.88 |
Mean aspartate aminotransferase, (±SD, IU/L) |
55.6 ± 75.8 |
Mean alanine transaminase, (±SD, IU/L) |
56.1 ± 98.3 |
Mean total bilirubin, (±SD, mg/dL) |
2.82 ± 5.72 |
Mean CRP, (±SD, mg/dL) |
3.10 ± 5.18 |
Insomnia before hospitalization, n (%) |
8 (12.5) |
Regularly taking sleeping drugs, n (%) |
7 (10.9) |
Brotizolam |
6 |
Triazolam |
1 |
Lemborexant |
0 (0) |